Renalytix plc terminates formal sale process amid strategic realignment and market reaction
Renalytix plc, a prominent player in artificial intelligence-enabled in vitro diagnostics, has officially terminated its Formal Sale Process, citing a lack of viable acquisition offers ... Read More
FDA gives green light to Guardant Health’s Shield blood test: A game-changer in colorectal cancer screening and Medicare coverage
In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Guardant Health, Inc.'s Shield blood test as a primary screening option for ... Read More